Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Practitioners hesitancy to start new medications due to perceived titration complexity, incomplete understanding of drug interactions, and uncertainty of monitoring tools and goals of care, coupled with a belief that GLP-1R agonists requiring subcutaneous injections would not be well received by patients are major barriers to optimal use
DPP-4 Inhibitors: What Is Their Place in Therapy
Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase
Over the past century, from the earliest use of ketogenic diets to treat epilepsy, it has been confirmed that metabolic intervention can control seizures
US$ 26.95
US$ 26.12
US$ 21.03
US$ 21.89
